With our partner Salesforce, unify sales, marketing and customer service. Accelerate your growth!
Gleamer, a global player in artificial intelligence applied to medical imaging, has established itself as a reference in digital health. Founded in 2017, the Parisian company designed Gleamer Copilot®, a suite of AI tools deployed in 2,000 establishments across 40 countries. These solutions, such as BoneView for traumatic injuries or BreastView for mammograms, have already made it possible to process more than 30 million examinations per year. In France, they are adopted by 65% of university hospitals, reinforcing the impact of national technological innovation.
With its new OncoView project, the company aims to revolutionize oncological imaging. This AI module is designed to assist radiologists in the detection, measurement and monitoring of cancerous lesions, in particular targeting pulmonary and bone metastatic locations. Gleamer thus aims to reduce diagnostic errors, improve the effectiveness of treatments and lay the foundations for personalized medicine. “Within ten years, artificial intelligence will be essential in the interpretation of radiology exams,” says Christian Allouche, co-founder and CEO of Gleamer.
We were unable to confirm your registration.
Your registration is confirmed.
Gleamer’s approach is based on close collaboration with French healthcare establishments, industrial partners and an R&D team specializing in AI and clinical data. By combining local expertise and international influence, the company helps position France as a key player in digital health. Its solutions, validated by more than 25 scientific publications, demonstrate worldwide recognition for their reliability and effectiveness.
Selected as part of the France 2030 program, Gleamer will benefit from co-financing of 4.5 million euros for the development of OncoView. In total, 18 million euros will be invested over five years in this project, which marks a major step in the diversification of the company’s tools. Since its creation, Gleamer has raised 36 million euros from Supernova Invest, XAnge, Elaia, Heal Capital and Bpifrance, illustrating the attractiveness of its technological vision among investors.
